Pristiq is a medication that is widely prescribed for depression, anxiety, and other mental health conditions. While it can be effective in treating these conditions, it does come with potential side effects and interactions. It's important to understand how Pristiq works and the effects it has on your body. In this article, we will discuss exactly how Pristiq works, what dosages are available, and the potential side effects you should be aware of before taking the medication.
Pristiq is a prescription medication used to treat major depressive disorder (MDD). It belongs to a class of drugs called selective serotonin and norepinephrine reuptake inhibitors (SNRIs). SNRIs work by increasing the levels of two neurotransmitters in the brain that are known to affect mood: serotonin and norepinephrine.
Pristiq is available as an extended-release tablet. The starting dose is usually 50 mg once daily.
Common side effects of Pristiq include headache, nausea, diarrhea, dry mouth, increased sweating, and dizziness. Pristiq can also cause sexual side effects such as decreased libido and difficulty achieving orgasm.
Pristiq may interact with other medications such as monoamine oxidase inhibitors (MAOIs) and blood thinners.
The usual starting dose is 50 mg per day, but it can range from 25 mg to 100 mg. The dose may be increased by your provider if needed. However, the maximum recommended dose is 100 mg per day.
Possible side effects of Pristiq include nausea, vomiting, stomach pain, constipation, diarrhea, headache, dry mouth, drowsiness, tiredness, trouble sleeping, dizziness, sweating, or feeling anxious or nervous. These side effects are usually mild and go away with time.
Pristiq is an antidepressant that belongs to a class of drugs called selective serotonin and norepinephrine reuptake inhibitors (SSNRIs). These drugs are used to treat major depressive disorder and other mental disorders.
The most common side effects of Pristiq include nausea, headache, dizziness, fatigue, sweating, dry mouth, constipation, and decreased appetite. Other side effects include anxiety, insomnia, sexual dysfunction, and weight gain.
Pristiq may also cause serious side effects such as bleeding, seizure, mania, and serotonin syndrome.
If you are taking Pristiq, it is important to be aware of the potential side effects and to take the medication as directed. Here are some tips for taking Pristiq safely:
-Pristiq can cause dizziness or drowsiness, so it is important not to drink alcohol or operate heavy machinery while taking the medication.
-It is also important to avoid suddenly stopping Pristiq, as this can cause withdrawal symptoms.
Pristiq can be a very effective medication for treating depression however ,it's important to know about the dosage and side effects before you start taking it.
1.
Non-Factor Therapies in Hemophilia: Cutting-Edge Approaches to Individualize Care
2.
FDA approves Blenrep for relapsed or refractory multiple myeloma
3.
X-ray and radar technology combined to reduce cancer screening risks
4.
Extended Maintenance with Imatinib Enhances Disease-Free Survival in High-Risk GIST.
5.
Researchers discuss HER2-low and HER2-zero in breast cancer
1.
Understanding Mesenteric Masses: Symptoms, Diagnosis, and Treatment Options
2.
Liposomal Doxorubicin and Mitomycin in Modern Cancer Treatment
3.
The New Era of Oncology: Key Updates and Clinical Insights
4.
HIPEC in Platinum-Sensitive Ovarian Cancer: A Promising Yet Controversial Option
5.
Theranostics and Radioligand Therapy: Precision Cancer Care with Targeted Radionuclides
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Exploring Potentials of Lorlatinib: The Third Generation ALK-TKI Through CROWN Trial
2.
Managing ALK Rearranged Non-Small Cell Lung Cancer with Lorlatinib - Part I
3.
Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part V
4.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part II
5.
Expert Group meeting with the management of EGFR mutation positive NSCLC - Part III
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation